A tumor selective chemotherapy. Can this be managed by an algorithm based on the non- Markovian population dynamics?

A non-Markovian theory of population dynamics is to simulate the anti-cancer drug distribution between malignant and the hosting normal cell pools. The model takes into account both the cell life span and the proliferation rate differences. This new simulation approach looks promising for its potential to optimize a chemotherapeutic strategy by choosing the scheme with a higher degree of the drug-tumor selectivity.The pre-test designed simulation mode fits nicely the experimental data on Porphylleren-MC16 (PMC16) pharmacokinetics patterns including the allometric plots revealed for this new medicinal porphyrined-fullerene nanoparticle possessing some anti-cancer potential and intervening into the oxygen-independent ATP production mechanisms.

[1]  H. Penefsky,et al.  Immediate effects of anticancer drugs on mitochondrial oxygen consumption. , 2003, Biochemical pharmacology.

[2]  B. Weber,et al.  Radioimmunotherapy targeting the extra domain B of fibronectin in C6 rat gliomas: a preliminary study about the therapeutic efficacy of iodine-131-labeled SIP(L19). , 2006, Nuclear medicine and biology.

[3]  J. Soria,et al.  Molecular targeting: targeting angiogenesis in solid tumors. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

[4]  S. Rezayat,et al.  The porphyrin-fullerene nanoparticles to promote the ATP overproduction in myocardium: 25Mg2+-magnetic isotope effect. , 2009, European journal of medicinal chemistry.

[5]  Donald J. Birkett,et al.  Pharmacokinetics Made Easy , 1999 .

[6]  K. Naidoo,et al.  Modelling molecular structure and reactivity in biological systems , 2006 .

[7]  J. Gautier.  Drug Safety Evaluation , 2017, Methods in Molecular Biology.

[8]  Igor Volovich,et al.  Quantum Theory and Its Stochastic Limit , 2002 .

[9]  S. Rezayat,et al.  New porphyrin adduct of fullerene-C60 : A promising nanotool for medicinal use in the heart muscle hypoxia cases , 2008 .

[10]  K. Chisholm,et al.  Tamoxifen and epigallocatechin gallate are synergistically cytotoxic to MDA-MB-231 human breast cancer cells , 2004, Anti-cancer drugs.

[11]  A. Nadal,et al.  Molecular biology of laryngeal squamous cell carcinoma , 2002, Virchows Archiv.

[12]  Elke S. Bergmann-Leitner,et al.  Editorial [Hot Topic: Anti-Cancer Drugs Executive Editor: Elke Bergmann-Leitner] , 2005 .